Is Adaptive Biotechnologies Corp (ADPT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.5% / 30% | 9.9% / 30% | 2.2% / 30% | 3.41% / 5% | ✓ HALAL |
| DJIM | 3.5% / 33% | 9.9% / 33% | 2.2% / 33% | 3.41% / 5% | ✓ HALAL |
| MSCI | 15.4% / 33% | 44.3% / 33% | 9.8% / 33% | 3.41% / 5% | ✗ NOT HALAL |
| S&P | 3.5% / 33% | 9.9% / 33% | 2.2% / 33% | 3.41% / 5% | ✓ HALAL |
| FTSE | 15.4% / 33% | 44.3% / 33% | 9.8% / 50% | 3.41% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 74.2% | |
| Operating Margin | -17.8% | |
| Net Margin | -21.5% | |
| Return on Equity (ROE) | -27.8% | |
| Return on Assets (ROA) | -6.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$46M |
| Free Cash Flow | -$49M |
| Total Debt | $79M |
| Debt-to-Equity | 93.5 |
| Current Ratio | 3.3 |
| Total Assets | $513M |
Price & Trading
| Last Close | $13.96 |
| 50-Day MA | $15.88 |
| 200-Day MA | $14.55 |
| Avg Volume | 2.0M |
| Beta | 2.3 |
|
52-Week Range
$6.67
| |
About Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Purification Calculator
As a halal stock with 3.41% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Adaptive Biotechnologies Corp (ADPT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Adaptive Biotechnologies Corp is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Adaptive Biotechnologies Corp's debt ratio?
Adaptive Biotechnologies Corp's debt ratio is 3.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 15.4%.
Does Adaptive Biotechnologies Corp require dividend purification?
Yes, Adaptive Biotechnologies Corp has an impermissible income ratio of 3.41%, which means 3.41% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Adaptive Biotechnologies Corp's key financial metrics?
Adaptive Biotechnologies Corp has a market capitalization of $1.9B, and revenue of $277M. The company maintains a gross margin of 74.2% and a net margin of -21.5%. Return on equity stands at -27.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.